NM_002691.4(POLD1):c.495A>G (p.Gln165=) AND not provided
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Dec 9, 2019
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001698318.9
Allele description [Variation Report for NM_002691.4(POLD1):c.495A>G (p.Gln165=)]
NM_002691.4(POLD1):c.495A>G (p.Gln165=)
Condition(s)
- Synonyms:
- none provided
- Identifiers:
- MedGen: C3661900
-
Homo sapiens RAB10, member RAS oncogene family, mRNA (cDNA clone MGC:4875 IMAGE:...
Homo sapiens RAB10, member RAS oncogene family, mRNA (cDNA clone MGC:4875 IMAGE:3464547), complete cdsgi|12654156|gb|BC000896.1|Nucleotide
-
1,4-alpha-Glucan Branching Enzyme
1,4-alpha-Glucan Branching EnzymeIn glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. EC ...<br/>Year introduced: 1991(1976)MeSH
-
Chondroitinases and Chondroitin Lyases
Chondroitinases and Chondroitin LyasesEnzymes which catalyze the elimination of glucuronate residues from chondroitin A, B, and C or which catalyze the hydrolysis of sulfate groups of the 2-acetamido-2-deoxy-D-gal...<br/>Year introduced: 1998(1976)MeSH
-
Procalcitonin
ProcalcitoninA peptide prohormone precursor of CALCITONIN. It is normally present at low levels in serum, but is released into the bloodstream, primarily from neuroendocrine cells in the l...<br/>Year introduced: 2019MeSH
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024